International Urology and Nephrology

, Volume 45, Issue 5, pp 1423–1428 | Cite as

Non-tuberculous mycobacterial PD peritonitis in Australia

  • Simon H. Jiang
  • Darren M. Roberts
  • Philip A. Clayton
  • Meg Jardine
Nephrology - Original Paper



Peritonitis can be a severe complication of peritoneal dialysis (PD) due to associated morbidity and mortality. Non-tuberculous mycobacteria (NTM) are a rare cause of PD peritonitis, with high rates of catheter removal and conversion to haemodialysis, and a reported mortality as high as 40 %. The incidence, culprit NTM species, and outcomes associated with PD peritonitis have not been described in many countries, including Australia.


We examined the Australia and New Zealand Dialysis and Transplant Registry from 1 October 2003 to 31 December 2009 for all prevalent peritoneal dialysis patients. Patient characteristics, organisms, treatment and outcome for all NTM PD peritonitis episodes were obtained.


Twelve cases of NTM PD peritonitis were reported, including the first reports of infection due to Mycobacterium hassiacum and Mycobacterium neoaurum. The incidence of NTM PD peritonitis was approximately 1 per 1000 PD patient-years. Recovery occurred in 11 patients, including 3 without removal of their Tenckhoff catheters. A range of antibiotics were utilised. One patient died of sclerosing peritonitis 5 months after diagnosis of PD peritonitis.


Non-tuberculous mycobacteria PD peritonitis is a rare cause of peritonitis, and mortality may be lower than previously reported. Catheter removal occurred in the majority of patients, and adverse outcomes were not observed for those in whom it was retained.


Incidence Mortality Mycobacterium Peritoneal dialysis Peritonitis Treatment 



Medical and nursing staff from Australian Renal units for their contributions to the database.

Conflict of interest

The authors declare that they have not conflicts of interest.


  1. 1.
    Brown F, Gulyani A, Dent H et al (2011) Chapter 6. Peritoneal dialysis. In: ANZDATA Registry 2011 Report:
  2. 2.
    Li PK, Szeto CC, Piraino B et al (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30(4):393–423PubMedCrossRefGoogle Scholar
  3. 3.
    Brown-Elliott BA, Wallace RJ Jr (2002) Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15(4):716–746PubMedCrossRefGoogle Scholar
  4. 4.
    Woo PC, Tsoi HW, Leung KW et al (2000) Identification of Mycobacterium neoaurum isolated from a neutropenic patient with catheter-related bacteremia by 16S rRNA sequencing. J Clin Microbiol 38(9):3515–3517PubMedGoogle Scholar
  5. 5.
    Morimoto Y, Chan ED, Heifets L et al (2007) Pulmonary infection with Mycobacterium neoaurum identified by 16S ribosomal DNA sequence. J Infect 54(4):e227–e231PubMedCrossRefGoogle Scholar
  6. 6.
    Schroder KH, Naumann L, Kroppenstedt RM et al (1997) Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium. Int J Syst Bacteriol 47(1):86–91PubMedCrossRefGoogle Scholar
  7. 7.
    Song Y, Wu J, Yan H et al (2012) Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 27(4):1639–1644PubMedCrossRefGoogle Scholar
  8. 8.
    Jiang SH, Senanayake S, Talaulikar GS (2011) Peritoneal dialysis-related peritonitis due to Mycobacterium smegmatis. Perit Dial Int 31(2):215–216PubMedGoogle Scholar
  9. 9.
    LaRocco MT, Mortensen JE, Robinson A (1986) Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis 4(2):161–164PubMedCrossRefGoogle Scholar
  10. 10.
    Renaud CJ, Subramanian S, Tambyah PA et al (2011) The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton) 16(2):174–179CrossRefGoogle Scholar
  11. 11.
    Pulliam JP, Vernon DD, Alexander SR et al (1983) Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2(6):610–614PubMedGoogle Scholar
  12. 12.
    Jiang SH, Roberts DM, Dawson AH, Jardine M (2012) Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature. BMC Nephrol 13:35. doi: 10.1186/1471-2369-13-35
  13. 13.
    Fahim M, Hawley CM, McDonald SP et al (2010) Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis 55(4):690–697PubMedCrossRefGoogle Scholar
  14. 14.
    The CARI guidelines—Treatment of peritoneal dialysis-associated peritonitis in adults (2004).
  15. 15.
    Falkinham JO 3rd (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9(2):177–215PubMedGoogle Scholar
  16. 16.
    Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRefGoogle Scholar
  17. 17.
    Rigby RJ, Hawley CM (1998) Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 13(1):154–159PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Simon H. Jiang
    • 1
    • 2
  • Darren M. Roberts
    • 1
    • 2
  • Philip A. Clayton
    • 1
    • 3
  • Meg Jardine
    • 2
    • 4
  1. 1.Department of Renal MedicineRoyal Prince Alfred HospitalCamperdownAustralia
  2. 2.Department of Renal MedicineConcord General and Repatriation HospitalConcordAustralia
  3. 3.Australia and New Zealand Dialysis and Transplant RegistryRoyal Adelaide HospitalAdelaideAustralia
  4. 4.The George Institute for Global HealthCamperdownAustralia

Personalised recommendations